El año pasado, Boston Scientific Corp generó 4.64B USD en su segmento con mejor rendimiento, Interventional Cardiology Therapies. United States realizó la mayor aportación, representando 12.86B USD el año pasado. Para el último trimestre, Boston Scientific Corp reportó unos ingresos de 1.33B USD para el periodo finalizado el 2026-06-30, procedentes del segmento con mejor rendimiento, Interventional Cardiology Therapies. United States aportó los mayores ingresos, alcanzando los 3.43B USD.

Por negocio

Ingresos operativos

Proporción

Anual

Anual

Trimestral

Interventional Cardiology Therapies

Electrophysiology

Endoscopy

Urology

Cardiac Rhythm Management

Watchman

Neuromodulation

Peripheral Interventions

Medsurg Watchman

Other

Global Specialty Pharmaceuticles

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Interventional Cardiology Therapies

4.64B(23.11%)

2.65B(14.48%)

2.42B(15.58%)

2.23B(16.26%)

3.04B(25.56%)

2.30B(23.19%)

2.82B(26.43%)

Electrophysiology

3.33B(16.56%)

1.90B(10.43%)

800.00M(5.16%)

585.00M(4.27%)

365.00M(3.07%)

287.00M(2.90%)

329.00M(3.09%)

Endoscopy

2.92B(14.53%)

2.69B(14.71%)

2.48B(16.00%)

2.22B(16.21%)

2.14B(18.01%)

1.78B(17.96%)

1.89B(17.77%)

Urology

2.71B(13.50%)

2.20B(12.05%)

1.96B(12.66%)

1.77B(12.94%)

1.58B(13.32%)

1.29B(12.97%)

1.41B(13.26%)

Cardiac Rhythm Management

2.33B(11.62%)

2.28B(12.48%)

2.22B(14.30%)

2.10B(15.33%)

2.02B(16.98%)

1.70B(17.19%)

1.94B(18.20%)

Watchman

1.96B(9.75%)

1.52B(8.30%)

1.27B(8.21%)

1.02B(7.44%)

--(--)

Neuromodulation

1.20B(5.97%)

1.11B(6.06%)

976.00M(6.29%)

917.00M(6.69%)

909.00M(7.65%)

761.00M(7.68%)

873.00M(8.19%)

Peripheral Interventions

996.00M(4.96%)

2.41B(13.20%)

2.11B(13.60%)

1.90B(13.86%)

1.82B(15.31%)

1.58B(15.91%)

1.39B(13.06%)

Medsurg Watchman

--(--)

1.52B(8.30%)

1.27B(8.21%)

1.02B(7.44%)

--(--)

Other

--(--)

-60.00M(-0.44%)

--(--)

Global Specialty Pharmaceuticles

--(--)

13.00M(0.11%)

219.00M(2.21%)

--(--)

Por región

Ingresos operativos

Proporción

Anual

Anual

Trimestral

United States

EMEA (Europe, Middle East and Africa)

Asia Pacific

Latin America and Canada

Other Foriegn

Medical Devices-United States

Medical Device - OUS

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

United States

12.86B(64.09%)

10.21B(60.96%)

8.43B(59.16%)

7.63B(60.18%)

6.90B(58.05%)

5.51B(55.56%)

6.10B(56.80%)

EMEA (Europe, Middle East and Africa)

3.45B(17.19%)

3.23B(19.27%)

2.86B(20.05%)

2.53B(19.92%)

2.52B(21.18%)

2.10B(21.15%)

2.26B(21.09%)

Asia Pacific

3.08B(15.34%)

2.69B(16.04%)

2.40B(16.85%)

2.12B(16.68%)

2.07B(17.41%)

1.78B(17.97%)

1.90B(17.68%)

Latin America and Canada

678.00M(3.38%)

624.00M(3.73%)

560.00M(3.93%)

469.00M(3.70%)

386.00M(3.25%)

307.00M(3.10%)

395.00M(3.68%)

Other Foriegn

--(--)

-60.00M(-0.47%)

--(--)

Medical Devices-United States

--(--)

10.00M(0.08%)

193.00M(1.95%)

70.00M(0.65%)

Medical Device - OUS

--(--)

4.00M(0.03%)

27.00M(0.27%)

11.00M(0.10%)